ArQule to Participate in the BTIG Biotechnology Conference on Monday, August 12, 2019
BURLINGTON, Mass.–(BUSINESS WIRE)–$ARQL #arql–ArQule, Inc. (Nasdaq:ARQL) today announced that Dr. Brian Schwartz, Chief Medical Officer and Head of Research and…
Pharmaceuticals, Biotechnology and Life Sciences
BURLINGTON, Mass.–(BUSINESS WIRE)–$ARQL #arql–ArQule, Inc. (Nasdaq:ARQL) today announced that Dr. Brian Schwartz, Chief Medical Officer and Head of Research and…
PHILADELPHIA–(BUSINESS WIRE)–#Fibrosis–SFA Therapeutics, Inc. announced today that the company has filed an FDA application requesting Orphan Drug Designation (ODD) for…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global cancer stem cell therapeutics market is expected to grow by USD 219.43 million during the period 2019-2023,…
Paul Meister Elected Chairman of the Board Investor Call at 8:30 a.m. ET to Discuss Leadership Transition and Second Quarter…
LONDON–(BUSINESS WIRE)–#Biotechnology–The global blood cancer therapeutics market is expected to grow by USD 12.63 billion by 2023, according to the…
– IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in previously untreated advanced bladder cancer…
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) announced today that the Phase 3 Rivipansel (GMI-1070): Evaluating Safety, Efficacy and Time to Discharge…
Breakthrough offering combines the power of machine learning with the transparency of Evaluate’s renowned analytical approach for the most accurate…
PLATTSBURGH, N.Y.–(BUSINESS WIRE)–Together global partners, MEDISCA, MEDISCA Network, and LP3 Network are excited to announce that they will be hosting…
Consultation and resources available free-of-charge to local community SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Magellan Health, Inc. (NASDAQ: MGLN) today announced that it will…